Bengaluru-based healthtech startup SugarStrings.ai has developed a non-invasive DNA test that screens users for more than 7,442 genetic disorders, and aims to make genetic testing more accessible and privacy-focused.
For years, Tony Jose worked in genomics research and diagnostics, studying how genetic conditions shape human health.
During his time as CEO of Clevergene Biocorp, one observation kept returning.
Many genetic disorders may be classified as rare, but together they affect far more people than most people realise.
“Genetic disorders are essentially rare diseases.
But while they are individually rare, as a group it becomes a burden on the population.
SugarStrings says its proprietary machine learning-based crawler identifies novel mutations with 94.89% accuracy, allowing it to…
Genetic testing is helping doctors identify rare diseases earlier, opening the door to treatment options before symptoms appear.
Children's Hospital of Philadelphia Researchers Develop AI-Driven Tool to Aid in Selecting Genetic Tests for Diagnosis of Rare…
The team hopes the open-source AI framework will help decode rare diseases and provide equitable access to precision medicine.
A new rapid blood test for newborns could potentially detect genetic mutations linked to thousands of rare diseases all at once,…
Sanofi India's AccelRare tool swiftly identifies over 300 rare diseases, enhancing early diagnosis and treatment accuracy for…
